Literature DB >> 21116680

The role of HLA-G in immunity and hematopoiesis.

Edgardo D Carosella1, Silvia Gregori, Nathalie Rouas-Freiss, Joel LeMaoult, Catherine Menier, Benoit Favier.   

Abstract

The non-classical HLA class I molecule HLA-G was initially shown to play a major role in feto-maternal tolerance. Since this discovery, it has been established that HLA-G is a tolerogenic molecule which participates to the control of the immune response. In this review, we summarize the recent advances on (1) the multiple structures of HLA-G, which are closely associated with their role in the inhibition of NK cell cytotoxicity, (2) the factors that regulate the expression of HLA-G and its receptors, (3) the mechanism of action of HLA-G at the immunological synapse and through trogocytosis, and (4) the generation of suppressive cells through HLA-G. Moreover, we also review recent findings on the non-immunological functions of HLA-G in erythropoiesis and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116680     DOI: 10.1007/s00018-010-0579-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  167 in total

1.  Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.

Authors:  N Rouas-Freiss; R M Gonçalves; C Menier; J Dausset; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  HLA-G: from biology to clinical benefits.

Authors:  Edgardo D Carosella; Philippe Moreau; Joël Lemaoult; Nathalie Rouas-Freiss
Journal:  Trends Immunol       Date:  2008-02-04       Impact factor: 16.687

Review 3.  Induction of ILT expression on nonprofessional antigen presenting cells: Clinical applications.

Authors:  Christian A Gleissner; Thomas J Dengler
Journal:  Hum Immunol       Date:  2009-05       Impact factor: 2.850

4.  Blood stem cells emerge from aortic endothelium by a novel type of cell transition.

Authors:  Karima Kissa; Philippe Herbomel
Journal:  Nature       Date:  2010-02-14       Impact factor: 49.962

5.  HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.

Authors:  B Riteau; N Rouas-Freiss; C Menier; P Paul; J Dausset; E D Carosella
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Disulfide bond-mediated dimerization of HLA-G on the cell surface.

Authors:  Jonathan E Boyson; Robert Erskine; Mary C Whitman; Michael Chiu; Julie M Lau; Louise A Koopman; Markus M Valter; Pavla Angelisova; Vaclav Horejsi; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-26       Impact factor: 11.205

7.  CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

Authors:  Abderrahim Naji; Solene Le Rond; Antoine Durrbach; Irene Krawice-Radanne; Caroline Creput; Marina Daouya; Julien Caumartin; Joel LeMaoult; Edgardo D Carosella; Nathalie Rouas-Freiss
Journal:  Blood       Date:  2007-09-05       Impact factor: 22.113

8.  Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.

Authors:  Ana S López; Estibaliz Alegre; Joël LeMaoult; Edgardo Carosella; Alvaro González
Journal:  Mol Immunol       Date:  2006-02-21       Impact factor: 4.407

9.  Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.

Authors:  F Colucci; E Rosmaraki; S Bregenholt; S I Samson; V Di Bartolo; M Turner; L Vanes; V Tybulewicz; J P Di Santo
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

10.  Recruitment of activation receptors at inhibitory NK cell immune synapses.

Authors:  Nicolas Schleinitz; Michael E March; Eric O Long
Journal:  PLoS One       Date:  2008-09-26       Impact factor: 3.240

View more
  19 in total

Review 1.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

2.  Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.

Authors:  Emilie Lesport; Jeremy Baudhuin; Sylvie Sousa; Joel LeMaoult; Alessia Zamborlini; Nathalie Rouas-Freiss; Edgardo D Carosella; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2011-02-20       Impact factor: 9.261

Review 3.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

4.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

Review 5.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

6.  Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions.

Authors:  Jeremy Baudhuin; Julie Migraine; Valerie Faivre; Laure Loumagne; Anne-Claire Lukaszewicz; Didier Payen; Benoit Favier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-16       Impact factor: 11.205

7.  MiRNA-mediated control of HLA-G expression and function.

Authors:  Irit Manaster; Debra Goldman-Wohl; Caryn Greenfield; Daphna Nachmani; Pinchas Tsukerman; Yaron Hamani; Simcha Yagel; Ofer Mandelboim
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis.

Authors:  Rafael J Argüello; Carlos Vigliano; Patricia Cabeza-Meckert; Rodolfo Viotti; Fernando Garelli; Liliana E Favaloro; Roberto R Favaloro; Rubén Laguens; Susana A Laucella
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

9.  A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients.

Authors:  Gianluigi Zaza; Simona Granata; Federica Rascio; Paola Pontrelli; Maria Pia Dell'Oglio; Sharon Natasha Cox; Giovanni Pertosa; Giuseppe Grandaliano; Antonio Lupo
Journal:  BMC Med Genomics       Date:  2013-05-10       Impact factor: 3.063

10.  HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.

Authors:  Grazia Locafaro; Giada Amodio; Daniela Tomasoni; Cristina Tresoldi; Fabio Ciceri; Silvia Gregori
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.